LPC is a known inhibitor of the lung ctant activity and has the ability to penetrate directly into interfacial films to impair lowering of the alveolar surface tension during dynamic compression. Elevated LPC levels in the SP CI73T expressing cells could also explain the heightened sensitivity selleckbio towards exogenous stress described above. Generation of LPC cannot account for the decrease of PC mass in SP CI73T expressing cells, but additional factors, which directly interfere with the synthesis and packaging of PC, must also be responsible. This is in line with the observed grossly altered pattern of the fatty acid species of the different phospholipid classes, including PC in SP CI73T cells. AECII secrete the surfactant phospholipids into the alveolar space where it lowers surface tension.

Among phospholipids secreted by the I73T mutants PC was again decreased by 27% and LPC was increased by 57%, compatible with a reduced surfactant function. Treatment with methylprednisolone or hydroxychloro quine ameliorated the increase in intracellular and secreted LPC and decrease in secreted PC, but did not completely correct it. The capacity GSK-3 of the treatment with methylprednisolone and hydroxychloro quine to correct the lipid disturbances caused by I73T mutation represent one of the mechanisms by which these treatments are empirically helpful in some patients with I73T mutations. Lastly, the index patient with the I73T mutation in our previous study displayed a mild interstitial chronic inflammation and most of the infiltrated leukocytes were CD3 and CD4 T lymphocytes.

We found that cells with the I73T mutation released soluble fac tors into the medium that increase surface expression of CCR2 and CXCR1 on CD4 lymphocytes and CXCR1 on neutrophiles. When activated, the high affinity IL 8 receptor CXCR1 mediates antibacterial kill ing capacity. Increases in surface expression levels of CCR2 and CXCR1, respectively, might have the potential to modulate the pulmonary immune response with regard to antibacterial and profibrotic responses. However, the soluble factors involved in the induction of chemokine receptor expres sion as well as the functional consequences of this phe nomenon remain to be addressed in future studies. Conclusions We showed impaired proSP C processing, altered cellu lar stress tolerance and unfavorable changes of the sur factant lipid composition in a murine AECII model cell line.

Some of the demonstrated cellular aspects behind the Brefeldin A clinical trial disease could be modulated with drugs used in the therapy of ILD patients, thereby giving insight into their potential therapeutic mechanism on a cellular level. We also demonstrated that AECII with I73T mutation could signal to the surrounding cells of the immune system through secretion of soluble factors.